Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

30 June 2011

Malignancy after renal transplantation in the new era of immunosuppression

Ewa WatorekABCDEF, Maria BoratynskaACDF, Danuta SmolskaB, Dariusz PatrzalekD, Marian KlingerD

Ann Transplant 2011; 16(2): 14-18 :: ID: 881859

Abstract

Background: This retrospective single-center study was undertaken to assess the occurrence of de novo neoplasms in renal transplant recipients according to the immunosuppressive regimen and time after transplantation.
Material/Methods: Observation encompassed 1028 patients transplanted between the years 1983–2006 and followed for 0.5–23 years. Patients with skin cancer other than melanoma were excluded due to incomplete data collection.
Results: Malignancy appeared in 4.8% (49) of the patients after the period of 5.8±4.7 years at the age of 54±13 years. The most common malignancies were urinary tract tumors (22%) and non-Hodgkin lymphoma with post-transplant lymphoproliferative disease (PTLD) (16%). Malignancy occurred in 5.2% of patients on cyclosporine (CSA), azathioprine (AZA) and prednisone (P); in 3.4% of patients on mofetil mycophenolate (MMF) with CSA and P; in 3.3% of patients on MMF with tacrolimus (TAC) and P; and in 2 of 20 patients (10%) receiving AZA with P 15 years after transplantation. The regimen consisting of CSA, AZA with P could be distinguished by the higher risk of malignancy occurrence. The occurrence of malignancy was significantly earlier on MMF+TAC+P compared to other regimens (p<0.05). The highest incidence of malignancy on AZA with P could be attributed to the longer observation period.
Conclusions: In the new era of immunosuppression, despite lower occurrence, malignancy tends to appear earlier after the transplantation.

Keywords: Malignancy, Kidney Transplantation, immunosuppression

Add Comment 0 Comments

In Press

Original article  

Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center Experience

Ann Transplant In Press; DOI: 10.12659/AOT.947649  

Original article  

Outcomes of Combined Liver-Kidney Transplantation in Polycystic Liver and Kidney Disease

Ann Transplant In Press; DOI: 10.12659/AOT.947639  

Most Viewed Current Articles

03 Jan 2023 : Original article   6,872

Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...

DOI :10.12659/AOT.938467

Ann Transplant 2023; 28:e938467

15 Aug 2023 : Review article   6,817

Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation

DOI :10.12659/AOT.939750

Ann Transplant 2023; 28:e939750

16 May 2023 : Original article   6,561

Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...

DOI :10.12659/AOT.939258

Ann Transplant 2023; 28:e939258

28 May 2024 : Original article   5,900

Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...

DOI :10.12659/AOT.943281

Ann Transplant 2024; 29:e943281

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358